Slowly declining levels of viral RNA and DNA in DNA/recombinant modified vaccinia virus Ankara-vaccinated macaques with controlled simian-human immunodeficiency virus SHIV-89.6P challenges

Journal of Virology

Volumn 76, Issue 20, 2002, Pages 10147-10154

  Tang, Yuyang ^a   Villinger, Francois ^a   Staprans, Silvija I ^a   Amara, Rama Rao ^a   Smith, James M ^a   Herndon, James G ^a   Robinson, Harriet L ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; VIRUS DNA; VIRUS RNA; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; LYMPHOCYTE DEPLETION; MACACA; MONONUCLEAR CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VACCINATION; VACCINIA VIRUS; VIRUS CULTURE; VIRUS LOAD; VIRUS RECOMBINANT;

ANIMALS; DISEASE MODELS, ANIMAL; DNA, VIRAL; GENES, ENV; GENES, GAG; GENES, POL; GENETIC VECTORS; HIV INFECTIONS; HIV-1; HUMANS; LYMPH NODES; MACACA MULATTA; RECOMBINATION, GENETIC; RNA, VIRAL; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VACCINIA VIRUS; VIRUS INTEGRATION;

EID: 0036785549     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.20.10147-10154.2002     Document Type: Article

References (27)

1. Amara, R. R., F. Villinger, J. D. Altman, S. L. Lydy, S. P. O'Neil, S. Staprans, D. C. Montefiori, Y. Xu, J. G. Herndon, L. S. Wyatt, M. A. Candido, N. L. Kozyr, P. L. Earl, J. M. Smith, H.-L. Ma, B. D. Grimm, M. L. Hulsey, J. Miller, H. M. McClure, J. M. McNicholl, B. Moss, and H. L. Robinson.2001. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292:69-74.
2. Amara, R. R., F. Villinger, S. Staprans, J. D. Altman, D. Montefiori, N. L. Kozyr, Y. Xu, L. Wyatt, P. L. Earl, J. G. Herndon, H. M. McClure, B. Moss, and H. L. Robinson. 2002. Different patterns of immune responses but similar control of a mucusal immunodeficiency virus challenge by MVA and DNA/MVA vaccines. J. Virol. 76:7625-7631.
3. Barouch, D. H., J. Kuntsman, M. J. Kuruda, J. E. Schmitz, S. Santra, F. W. Peyeri, G. R. Krivulka, K. Beaudry, M. A. Lifton, D. A. Gargonne, D. Montefiori, M. G. Lewis, S. M. Wolinsky, and N. L. Letvin. 2002. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415:335-339.
4. Barouch, D. H., S. Santra, M. J. Kuroda, J. E. Schmitz, R. Plishka, A. Buckler-White, A. E. Gaitan, R. Zin, J. H. Nam, L. S. Wyatt, M. A. Lifton, C. E. Nickerson, B. Moss, D. C. Montefiori, V. M. Hirsch, and N. L. Letvin. 2001. Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination. J. Virol. 75:5151-5158.
5. Barouch, D. H, S. Santra, J. E. Schmitz, M. J. Kuroda, T. M. Fu, W. Wagner, M. Bilska, A. Craiu, X. X. Zheng, G. R. Krivulka, K. Beaudry, M. A. Lifton, C. E. Nickerson, W. L. Trigona, K. Punt, D. C. Freed, L. Guan, S. Dubey, D. Casimiro, A. Simon, M. E. Davies, M. Chastain, T. B. Strom, R. S. Gelman, D. C. Montefiori, and M. G. Lewis. 2000. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 290:486-492.
6. Chun, T. W., J. S. Justement, S. Moir, C. W. Hallahan, L. A. Ehler, S. Liu, M. McLaughlin, M. Dybul, J. M. Mican, and A. S. Fauci. 2001. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies. Proc. Natl. Acad. Sci. USA 98:253-258.
7. Desire, N., A. Dehee, V. Schneider, C. Jacomet, C. Goujon, P. M. Girard, W. Rozenbaum, and J. C. Nicolas. 2001. Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. J. Clin. Microbiol. 39:1303-1310.
8. Douek, D. C., J. M. Brenchley, M. R. Betts, D. R. Ambrozak, B. J. Hill, Y. Okamoto, J. P. Casazza, J. Kuruppu, K. Kunstman, S. Wolinsky, Z. Grossman, M. Dybul, A. Oxenius, D. A. Price, M. Connors, and R. A. Koup. 2002. HIV preferentially infects HIV-specific CD4+ T cells. Nature 417:95-98.
9. Finzi, D., J. Blankson, J. D. Siliciano, J. B. Margolick, K. Chadwick, T. Pierson, K. Smith, J. Lisziewicz, F. Lori, C. Flexner, T. C. Quinn, R. E. Chaisson, E. Rosenberg, B. Walker, S. Gange, J. Gallant, and R. F. Siliciano. 1999. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5:512-517.
10. Garzino-Demo, A., A. L. DeVico, F. Cocchi, and R. C. Gallo. 1998. Betachemokines and protection from HIV type 1 disease. AIDS Res. Hum. Retroviruses 14(Suppl. 2):S177-S184.
11. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
12. Izopet, J., G. Salama, C. Pasquier, K. Sandres, B. Marchou, P. Massip, and J. Puel. 1998. Decay of HIV-1 DNA in patients receiving suppressive antiretroviral therapy. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19: 478-483.
13. Izopet, J., C. Tamalet, C. Pasquier, K. Sandres, B. Marchou, P. Massip, and J. Puel. 1998. Quantification of HIV-1 proviral DNA by a standardized colorimetric PCR-based assay. J. Med. Virol. 54:54-59.
14. + T cells. J. Virol. 75:7973-7986.
15. Karlsson, A. C., M. Birk, S. Lindback, H. Gaines, J. E. Mittler, and A. Sonnerborg. 2001. Initiation of therapy during primary HIV type 1 infection results in a continuous decay of proviral DNA and a highly restricted viral evolution. AIDS Res. Hum. Retroviruses 17:409-416.
16. Levy, J. A., C. E. Mackewicz, and E. Barker. 1996. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol. Today 17:217-224.
17. McMichael, A. J., and S. L. Rowland-Jones. 2001. Cellular immune responses to HIV. Nature 410:980-987.
18. Pal, R., A. Garzino-Demo, P. D. Markham, J. Burns, M. Brown, R. C. Gallo, and A. L. DeVico. 1997. Inhibition of HIV-1 infection by the beta-chemokine MDC. Science 278:695-698.
19. Pierson, T., J. McArthur, and R. F. Siliciano. 2000. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu. Rev. Immunol. 18:665-708.
20. Powell, J. D., D. P. Bednarik, T. M. Folks, T. Jehuda-Cohen, F. Villinger, K. W. Sell, and A. A. Ansari. 1993. Inhibition of cellular activation of retroviral replication by CD8+ T cells derived from non-human primates. Clin. Exp. Immunol. 91:473-481.
21. Robinson, H. L. 2002. New hope for an AIDS vaccine. Nat. Rev. Immunol. 2:239-250.
22. Robinson, H. L., J. M. Smith, and R. R. Amara. 2000. AIDS vaccines: heterologous prime/boost strategies for raising protective T cell responses. AIDS Rev. 2:105-110.
23. Rubbert, A., D. Weissman, C. Combadiere, K. A. Pettrone, J. A. Daucher, P. M. Murphy, and A. S. Fauci. 1997. Multifactorial nature of noncytolytic CD8+ T cell-mediated suppression of HIV replication: beta-chemokine-dependent and -independent effects. AIDS Res. Hum. Retroviruses 13:63-69.
24. Schneider, J., S. C. Gilbert, C. M. Hannan, P. Degano, E. G. Sheu, M. Plebanski, and A. V. S. Hill. 1999. Induction of CD8+ T cells using heterologous prime-boost immunisation strategies. Immunol. Rev. 170:29-38.
25. Shiver, J. W., T. Fu, L. Chen, D. Casimiro, M. E. Davies, R. K. Evans, Z.-Q. Zhang, A. Simon, W. L. Trigona, S. Dubey, L. Huang, V. A. Harris, R. S. Long, L. Xiaoping, L. Handt, W. A. Schleif, L. Zhu, D. C. Freed, N. V. Persaud, L. Guan, K. Punt, A. Tang, M. Chen, K. A. Wilson, K. B. Collins, G. J. Heidecker, H. C. Perry, J. G. Joyce, K. M. Grimm, J. C. Cook, P. M. Keller, D. S. Kresock, H. Mach, R. D. Troutman, L. A. Iospi, D. M. Williams, Z. Xu, K. E. Bohannon, D. B. Volkin, D. Montefiori, A. Miura, G. R. Krivulka, M. A. Lifton, M. J. Kuroda, J. E. Schmitz, N. L. Letvin, M. J. Caulfield, A. J. Bett, R. Youil, D. C. Kaslow, and E. A. Emini. 2002. Replication-incompetent adenoviral vaccine vector elicits effective anti-immuno-deficiency virus immunity. Nature 415:331-335.
26. Tomaras, G. D., S. F. Lacey, C. B. McDanal, G. Ferrari, K. J. Weinhold, and M. L. Greenberg. 2000. CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression. Proc. Natl. Acad. Sci. USA 97:3503-3508.
27. Yang, O. O., and B. D. Walker. 1997. CD8+ cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication. Adv. Immunol. 66:273-311.